Source: PR Newswire

Press Release: Altaviz : Altaviz Gaining Strong Market Traction with Advent R400e, an Evolutionary Delivery Solution for Subretinal Gene Therapy

IRVINE, Calif., Nov. 9, 2021 /PRNewswire/ -- Altaviz, a designer, developer and manufacturer of medical devices and drug delivery platforms, has increased its organizational focus with the development of the Advent R400e, their groundbreaking delivery solution for subretinal gene therapy....

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Jack Auld's photo - Co-Founder & CEO of Altaviz

Co-Founder & CEO

Jack Auld

CEO Approval Rating

71/100

Read more